European Companies Search Engine
EU funding (€6,583,216): Rituximab in patients with acute myocardial infarction: a phase 2 placebo-controlled randomised clinical trial Hor22 Jan 2021 EU Research and Innovation programme "Horizon"
Overview
Text
The filing refers to a past date, and does not necessarily reflect the current state.
The visualizations for "Assistance Publique Hopitaux de Paris - EU funding (€6,583,216): Rituximab in patients with acute myocardial infarction: a phase 2 placebo-controlled randomised clinical trial"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.